Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarction
- 1 August 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 356 (9230) , 639-644
- https://doi.org/10.1016/s0140-6736(00)02606-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Age‐ and Gender‐Related Use of Low‐Dose Drug Therapy: The Need to Manufacture Low‐Dose Therapy and Evaluate the Minimum Effective DoseJournal of the American Geriatrics Society, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Clinical Effects of β-Adrenergic Blockade in Chronic Heart FailureCirculation, 1998
- Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial InfarctionNew England Journal of Medicine, 1998
- National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial InfarctionPublished by American Medical Association (AMA) ,1998
- Secondary prevention after high-risk acute myocardial infarction with low-dose acebutololThe American Journal of Cardiology, 1990
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.BMJ, 1980